Want to see IN:VALIANTORG full AI Analyst Report?
Top Page
Valiant Organics Limited
(VALIANTORG)
Select Model
Select Model
Rating:56Neutral
Price Target:
₹278.00
▼(-0.71% Downside)
Action:Reiterated
Date:06/18/26
The score is driven primarily by improving but still inconsistent financial performance (recovery in profitability and cash flow, but declining revenue and volatile margins/returns). Technicals are supportive with the stock trading above key moving averages, while valuation remains somewhat demanding at ~26x earnings without a dividend yield to support the case.
Positive Factors
Improved cash generation
Operating and free cash flow turning positive provides durable internal funding to support working capital and modest reinvestment without immediate reliance on external financing. Sustained OCF/FCF improvement would underpin operational resilience and discretionary capital allocation over months.
Negative Factors
Multi-year revenue drift
Prolonged top-line decline undermines the company’s ability to leverage fixed costs and sustain scale benefits. Even with recent profit recovery, shrinking or inconsistent revenues weaken long-term growth visibility and make margin recovery and return normalization harder to sustain.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved cash generation
Operating and free cash flow turning positive provides durable internal funding to support working capital and modest reinvestment without immediate reliance on external financing. Sustained OCF/FCF improvement would underpin operational resilience and discretionary capital allocation over months.
Read all positive factors
Valiant Organics Limited (VALIANTORG) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.58B
Dividend YieldN/A
Average Volume (3M)2.15K
Price to Earnings (P/E)23.5
Beta (1Y)0.96
Revenue Growth2.78%
EPS GrowthN/A
CountryIN
Employees1,073
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)11.86
Shares Outstanding28,034,610
10 Day Avg. Volume2,085
30 Day Avg. Volume2,152
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.75
Price to Sales (P/S)0.77
P/FCF Ratio12.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Valiant Organics Limited Business Overview & Revenue Model
Company Description
Founded in Mumbai, India, in 1984, Valiant Organics Limited operates as a chemical manufacturer, specializing in the production and distribution of specialty chemicals across India. Their diverse product portfolio encompasses a variety of chloroph...
How the Company Makes Money
Valiant Organics Limited primarily generates revenue by selling chemical products (including specialty chemical intermediates) to customers under supply contracts and purchase orders. Revenue is recognized from the sale of manufactured chemicals, ...
Valiant Organics Limited Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
64
Positive
Cash Flow
52
Neutral
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 7.39B | 7.19B | 7.23B | 10.52B | 11.53B |
| Gross Profit | 2.13B | 2.62B | 470.01M | 1.81B | 2.17B |
| EBITDA | 996.99M | 615.51M | 425.75M | 1.77B | 2.12B |
| Net Income | 332.36M | -37.36M | -83.91M | 881.21M | 1.13B |
Balance Sheet | |||||
| Total Assets | 12.31B | 11.83B | 12.48B | 12.39B | 11.92B |
| Cash, Cash Equivalents and Short-Term Investments | 21.43M | 131.53M | 71.02M | 456.71M | 499.47M |
| Total Debt | 2.56B | 2.49B | 2.57B | 2.74B | 3.63B |
| Total Liabilities | 4.71B | 4.58B | 5.19B | 4.99B | 5.43B |
| Stockholders Equity | 7.59B | 7.25B | 7.29B | 6.89B | 6.13B |
Cash Flow | |||||
| Free Cash Flow | 439.27M | 256.03M | 90.70M | 862.19M | -1.53B |
| Operating Cash Flow | 774.59M | 564.32M | 840.00M | 2.38B | -307.47M |
| Investing Cash Flow | -898.89M | -209.61M | -649.88M | -1.43B | -1.24B |
| Financing Cash Flow | 71.27M | -318.13M | -231.19M | -1.12B | 1.67B |
Valiant Organics Limited Technical Analysis
Negative
280.00
Price Trends
285.92
Negative
264.92
Positive
274.81
Negative
Market Momentum
-3.34
Positive
44.10
Neutral
44.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VALIANTORG, the sentiment is Negative. The current price of 280 is below the 20-day moving average (MA) of 282.63, below the 50-day MA of 285.92, and above the 200-day MA of 274.81, indicating a bearish trend. The MACD of -3.34 indicates Positive momentum. The RSI at 44.10 is Neutral, neither overbought nor oversold. The STOCH value of 44.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:VALIANTORG.
Valiant Organics Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹395.81B | 59.16 | ― | 0.23% | 41.05% | 124.02% | |
67 Neutral | ₹9.16B | 11.79 | ― | 0.38% | 7.53% | 36.87% | |
63 Neutral | ₹13.52B | 21.23 | ― | 0.24% | 14.36% | 64.30% | |
58 Neutral | ₹71.53B | 22.83 | ― | 0.47% | 11.76% | 25.41% | |
56 Neutral | ₹7.58B | 23.53 | ― | ― | 2.78% | ― | |
56 Neutral | ₹224.03B | 40.73 | ― | 0.44% | -4.13% | -21.05% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:VALIANTORG
Valiant Organics Limited
270.25
-139.80
-34.09%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,642.55
-313.90
-16.04%
IN:INDIAGLYCO
India Glycols Limited
1,067.25
63.35
6.31%
IN:INDOAMIN
Indo Amines Limited
126.25
-31.05
-19.74%
IN:NAVINFLUOR
Navin Fluorine International Limited
7,716.85
2,747.33
55.28%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
1,102.35
-153.05
-12.19%
Valiant Organics Limited Corporate Events
Valiant Organics Closes Trading Window Ahead of Quarterly Results
Jun 26, 2026
Valiant Organics Limited has announced the closure of its trading window for dealings in the company’s securities by directors, promoters, designated persons, connected persons, and their immediate relatives from July 1, 2026. The window wil...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.